Interview Prof. Maria do Carmo Fonseca
allautoe 0 GECP congresses entrevista news vídeo
Prof. Maria do Carmo Fonseca was the speaker of the “Lecture: Molecular Pathology: State of Art and Future”, a session that addressed the way molecular pathology has transformed the diagnosis and treatment of disease. “In the last 20 years we have assisted the development of more and more drugs that, in turn, are directed to specific molecular changes. Molecular pathology follows the needs created by the pharmaceutical industry that allows us to treat patients better and better,” he explains.
The challenges that this area faces were also addressed, and the investment was one of the main obstacles. “Technologies evolve, becoming increasingly complex and, therefore, more expensive. We are facing a challenge similar to that of innovative medicines and, therefore, we need to make a balance between investment to have new diagnostic technologies and your benefit “.
About the future, the expert believes that “innovations will continue to emerge.” He adds that “there are already technological innovations that will allow us to see much more molecular changes than those we see today. Each time new molecular changes are identified, the pharmaceutical industry will develop new medicines and, therefore, I anticipate good perspectives for patients “.